Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386919 · ClinicalTrials.gov registry record · Phase 2
Short Course of Radiation for Gliomas in Elderly Patients
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00386919 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT00386919, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
Patients with high grade brain tumors will be treated to test shortened course of radiation therapy with the use of precise, focused radiation with cyberknife.
Interventions
- PROCEDURE CyberKnife
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-04 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386919
The ClinicalTrials.gov registry entry for NCT00386919 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CyberKnife is the first listed.
NCT00386919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386919 about?
NCT00386919 is a clinical study titled "Short Course of Radiation for Gliomas in Elderly Patients". Patients with high grade brain tumors will be treated to test shortened course of radiation therapy with the use of precise, focused radiation with cyberknife.
What is the current status of trial NCT00386919?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2006-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00386919?
The interventions under investigation include: CyberKnife (PROCEDURE).
Who is sponsoring clinical trial NCT00386919?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.